Skip to Content

93 5721 (Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 8 mg (base) / 2 mg (base))

Pill with imprint 93 5721 is White, Round and has been identified as Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 8 mg (base) / 2 mg (base). It is supplied by Teva Pharmaceuticals USA Inc..

Buprenorphine/naloxone is used in the treatment of opiate dependence and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 8 mg (base) / 2 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for 93 5721

Buprenorphine hydrochloride and naloxone hydrochloride (sublingual) 8 mg (base) / 2 mg (base) 93 5721

Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual)

Imprint
93 5721
Strength
8 mg (base) / 2 mg (base)
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Narcotic analgesic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
3 - Moderate abuse potential
Labeler / Supplier
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC)
00093-5721
Inactive Ingredients
acesulfame potassium, citric acid anhydrous, corn starch, lactose monohydrate, magnesium stearate, mannitol, povidone k30, trisodium citrate dihydrate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.